Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 304 studies with search of: | "Camptothecin" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Completed |
Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung
|
||||
2 | Completed |
Pharmacology Study of Aerosolized Liposomal
|
||||
3 | Completed |
Polyglutamate Camptothecin in Treating Patients With Advanced Cancer
|
||||
4 | Recruiting |
Aerosol L9-NC and Temozolomide in Ewing's Sarcoma
|
||||
5 | Completed |
Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
|
||||
6 | Completed |
Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
|
||||
7 | Terminated |
Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction
|
||||
8 | Completed |
Pharmacology Study of Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin (L9NC)
|
||||
9 | Active, not recruiting |
Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity
|
||||
10 | Completed |
Aminocamptothecin in Treating Patients With Advanced or Recurrent Kidney Cancer
|
||||
11 | Recruiting |
Safety Study of ON 01910.Na in Combination With Irinotecan or Oxaliplatin
|
||||
12 | Recruiting |
A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid Tumors
|
||||
13 | Recruiting |
Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma
|
||||
14 | Completed |
A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and Cisplatin
|
||||
15 | Completed |
Multicenter Study of 9-Aminocamptothecin (9-AC) in Patients With Refractory Leukemia
|
||||
16 | Active, not recruiting |
Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas
|
||||
17 | Suspended |
Efficacy and Safety Evaluation of Pegamotecan (PEG-Camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma
|
||||
18 | Completed |
Nitrocamptothecin in Treating Patients With Metastatic Melanoma
|
||||
19 | Completed |
Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer
|
||||
20 | Completed |
Nitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |